Meeting
2013 ASCO Annual Meeting
Predictors of patient-reported toxicities from endocrine therapy: Importance of illness perceptions, treatment beliefs, and fear of recurrence.
Authors
Xinni Song
The Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, ON, Canada
Xinni Song , Susan Faye Dent , Shailendra Verma , Mark J. Clemons , Nadine A. Graham , Marc Bedard , Lise Paquet
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 31, 2013 (suppl; abstr 542)
DOI
10.1200/jco.2013.31.15_suppl.542
Abstract #
542
Poster Bd #
1E
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Adherence to hormonal therapy among commercially insured breast cancer patients.
First Author: Hui Zhao
Poster
2017 ASCO Annual Meeting
Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.
First Author: Jane Bayani
Poster
2016 ASCO Annual Meeting
Effect of elevated BMI on radiation toxicity in early stage breast cancer patients.
First Author: Jordan Silberg
Poster
2015 ASCO Annual Meeting
Prediction of late distant recurrence (DR) using the Prosigna (PAM50) test in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal women diagnosed with hormone receptor-positive (HR+) early breast cancer (EBC) allocated to 5yr of endocrine therapy (ET).
First Author: Anne-Vibeke Lænkholm